EP4 receptor activation in a murine model of Alzheimer's disease, EP4 deficiency or the EP4 antagonist ONO-AE3-208 decreased amyloid-β levels in the brain and improved the behavioral performance of the animals (Hoshino et al., 2012). The gene discussed is PTGER4; the disease is Alzheimer disease.